Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Non Insulin Dependent Diabetes Mellitus
100%
Hemoglobin A1c
66%
N Ethyl 2 [N (6 Methoxy 3 Pyridinyl) 2 Methylbenzenesulfonamido] N (3 Pyridinylmethyl)acetamide
66%
Cardiovascular Disease
66%
Clinical Study
33%
Heart Infarction
33%
Cerebrovascular Accident
33%
Placebo
33%
Cardiovascular Risk
33%
Medicine and Dentistry
Clinical Trial
100%
Maturity Onset Diabetes of the Young
100%
Cardiovascular System
100%
Body Mass Index
100%
Cardiovascular Disease
25%
Hemoglobin A1c
25%
N Ethyl 2 [N (6 Methoxy 3 Pyridinyl) 2 Methylbenzenesulfonamido] N (3 Pyridinylmethyl)acetamide
25%
Arm
12%
Cardiovascular Risk
12%
Placebo
12%
Myocardial Infarction
12%
Apoplexy
12%
Clinical Study
12%
Proportional Hazards Model
12%
Neuroscience
Body Mass Index
100%
Hemoglobin A1c
25%
Placebo
12%
Cerebrovascular Accident
12%
Myocardial Infarction
12%
Keyphrases
EMPA-REG OUTCOME Trial
14%